Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 203

1.

Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study.

Nakajima K, Kaneko G, Takahashi S, Matsuyama H, Shiina H, Ichikawa T, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Mizokami A; PROSTAT-BSI Investigators.

Int J Urol. 2018 May;25(5):492-499. doi: 10.1111/iju.13556. Epub 2018 Apr 6.

PMID:
29633398
2.

[8. How We Can Treat the Patients with Prostate Cancer-Surgical Option and Change over Time].

Shiina H, Sumura M, Kishi H, Yasumoto H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(2):208-218. doi: 10.6009/jjrt.2018_JSRT_74.2.208. Japanese. No abstract available.

3.

Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.

Miyake M, Tatsumi Y, Matsumoto H, Nagao K, Matsuyama H, Inamoto T, Azuma H, Yasumoto H, Shiina H, Fujimoto K; Nishinihon Uro-Oncology Collaborative Group.

BJU Int. 2018 May;121(5):764-773. doi: 10.1111/bju.14111. Epub 2018 Jan 21.

PMID:
29281857
4.

Computed tomography-based image-guided brachytherapy for cervical cancer: correlations between dose-volume parameters and clinical outcomes.

Kusada T, Toita T, Ariga T, Maemoto H, Hashimoto S, Shiina H, Kakinohana Y, Heianna J, Nagai Y, Kudaka W, Aoki Y, Murayama S.

J Radiat Res. 2018 Jan 1;59(1):67-76. doi: 10.1093/jrr/rrx065.

5.

Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy.

Inamoto T, Matsuyama H, Ibuki N, Komura K, Takahara K, Fujimoto K, Shiina H, Sakano S, Nagao K, Miyake M, Tatsumi Y, Yasumoto H, Azuma H; Nishinihon Uro-Oncology Collaborative Group.

J Urol. 2018 Apr;199(4):933-939. doi: 10.1016/j.juro.2017.10.019. Epub 2017 Oct 14.

PMID:
29037861
6.

Thermal Decomposition of Nitromethane and Reaction between CH3 and NO2.

Matsugi A, Shiina H.

J Phys Chem A. 2017 Jun 8;121(22):4218-4224. doi: 10.1021/acs.jpca.7b03715. Epub 2017 May 26.

PMID:
28521497
7.

[Laparoscopic Pyelolithotomy in a Horseshoe Kidney : A Case Report and Review of the Literature].

Yoshino T, Wake K, Sugitani T, Kodama K, Shiina H, Yasumoto H, Kadowaki A, Kawakami K.

Hinyokika Kiyo. 2017 Apr;63(4):157-161. doi: 10.14989/ActaUrolJap_63_4_157. Review. Japanese.

8.

1. Making a Diagnosis of Prostatic Disorders Based on the Recent Imaging Procedures.

Shiina H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(4):330-339. doi: 10.6009/jjrt.2017_JSRT_73.4.330. Japanese. No abstract available.

9.

Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma.

Mitsui Y, Shiina H, Kato T, Maekawa S, Hashimoto Y, Shiina M, Imai-Sumida M, Kulkarni P, Dasgupta P, Wong RK, Hiraki M, Arichi N, Fukuhara S, Yamamura S, Majid S, Saini S, Deng G, Dahiya R, Nakajima K, Tanaka Y.

Mol Cancer Res. 2017 Jul;15(7):884-895. doi: 10.1158/1541-7786.MCR-16-0444. Epub 2017 Feb 27.

10.

A Case Report of Bilateral Sarcomatoid Carcinoma of Adrenal Glands With Adrenal Insufficiency.

Ishikawa N, Nagase M, Takami S, Araki A, Ishikawa N, Koike C, Shiina H, Maruyama R.

Int J Surg Pathol. 2016 Dec;24(8):743-748. Epub 2016 Jun 27.

PMID:
27353077
11.

Changes in oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma treated in the last two decades: a retrospective analysis based on a multicenter collaborative study.

Miyake M, Tatsumi Y, Fujimoto K, Nagao K, Sakano S, Matsuyama H, Inamoto T, Azuma H, Yasumoto H, Shiina H; Nishinipon Uro-Oncology Collaborative Group.

Jpn J Clin Oncol. 2016 Dec;46(12):1148-1155. Epub 2016 Aug 30.

PMID:
27576438
12.

Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.

Mitsui Y, Chang I, Kato T, Hashimoto Y, Yamamura S, Fukuhara S, Wong DK, Shiina M, Imai-Sumida M, Majid S, Saini S, Shiina H, Nakajima K, Deng G, Dahiya R, Tanaka Y.

Oncotarget. 2016 Aug 2;7(31):49107-49121. doi: 10.18632/oncotarget.9470.

13.

Time-Resolved Broadband Cavity-Enhanced Absorption Spectroscopy behind Shock Waves.

Matsugi A, Shiina H, Oguchi T, Takahashi K.

J Phys Chem A. 2016 Apr 7;120(13):2070-7. doi: 10.1021/acs.jpca.6b01069. Epub 2016 Mar 28.

PMID:
26990289
14.

The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).

Inoue K, Matsuyama H, Fujimoto K, Hirao Y, Watanabe H, Ozono S, Oyama M, Ueno M, Sugimura Y, Shiina H, Mimata H, Azuma H, Nagase Y, Matsubara A, Ito YM, Shuin T.

Photodiagnosis Photodyn Ther. 2016 Mar;13:91-96. doi: 10.1016/j.pdpdt.2015.12.011. Epub 2016 Jan 2.

PMID:
26751700
15.

CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.

Mitsui Y, Chang I, Fukuhara S, Hiraki M, Arichi N, Yasumoto H, Hirata H, Yamamura S, Shahryari V, Deng G, Wong DK, Majid S, Shiina H, Dahiya R, Tanaka Y.

BMC Cancer. 2015 Dec 1;15:942. doi: 10.1186/s12885-015-1951-0.

16.

Tissue Chromogranin A Expression during Prostate Cancer Progression: Prediction of Chemosensitivity.

Mitsui Y, Arichi N, Hiraki M, Harada Y, Yasumoto H, Shiina H.

Urol J. 2015 Jul 1;12(3):2165-72.

17.

Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.

Fukuhara S, Chang I, Mitsui Y, Chiyomaru T, Yamamura S, Majid S, Saini S, Deng G, Gill A, Wong DK, Shiina H, Nonomura N, Lau YF, Dahiya R, Tanaka Y.

Oncotarget. 2015 Jun 30;6(18):16341-51.

18.

Versican is a potential therapeutic target in docetaxel-resistant prostate cancer.

Arichi N, Mitsui Y, Hiraki M, Nakamura S, Hiraoka T, Sumura M, Hirata H, Tanaka Y, Dahiya R, Yasumoto H, Shiina H.

Oncoscience. 2015 Mar 2;2(2):193-204. eCollection 2015.

19.

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.

Mitsui Y, Hirata H, Arichi N, Hiraki M, Yasumoto H, Chang I, Fukuhara S, Yamamura S, Shahryari V, Deng G, Saini S, Majid S, Dahiya R, Tanaka Y, Shiina H.

Oncotarget. 2015 Apr 20;6(11):9577-91.

20.

DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.

Fukuhara S, Chang I, Mitsui Y, Chiyomaru T, Yamamura S, Majid S, Saini S, Hirata H, Deng G, Gill A, Wong DK, Shiina H, Nonomura N, Dahiya R, Tanaka Y.

Oncotarget. 2014 Nov 30;5(22):11297-307.

Supplemental Content

Loading ...
Support Center